Delivery Order SPE2DB22D3501-SPE2DB25FXG87
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $25,703.05 for the supply of DUOVISC Viscoelastic System 1.05ML, a specialized ophthalmic medical device. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of July 24, 2025. The award was issued on July 23, 2025, by the Defense Logistics Agency's Medical Supply Chain, with performance to be executed at the contractor's Corporate Office location in...
- The Defense Logistics Agency awarded a $15,611.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Duovisc Viscoelastic System 1.05ML, a medical ophthalmic product. The contract was competitively awarded without a set-aside designation and is scheduled for completion by August 4, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a purchase under the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,134.15 for DUOVISC Viscoelastic System 1.05ML, a medical supply product, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed price contract carries no set-aside designation and will be performed at the awardee's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,378.05, is for the procurement of the DUOVISC Viscoelastic System 1.05ML medical product. The delivery order is placed under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $5,264.08 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply DUOVISC VISCOELASTIC SYSTEM 1.05ML. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with all supplies delivered by November 9, 2023. No set-aside designation was applied to this order, which was issued against an existing indefinite delivery contract...
- This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,650.10 firm-fixed price delivery order is for the DUOVISC VISCOELASTIC SYSTEM 1.05ML medical supply. This award is not subject to any set-aside requirements. As a major pharmaceutical distributor, Amerisourcebergen holds multiple Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract valued at $3,006.12 by the Defense Logistics Agency (DLA) to provide the DUOVISC VISCOELASTIC SYSTEM 0.75ML medical product. The contract has a completion date of March 7, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00, which serves as the primary vehicle for the...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order valued at five thousand dollars and twenty cents ($5,000.20) to supply DUOVISC viscoelastic system to the Defense Logistics Agency Troop Support Medical (DLA). Performance will take place in Conshohocken, Pennsylvania over one day from June 22nd to June 23rd, 2023. The DLA supports the medical supply needs of the United States Department of Defense, and this...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,512.20 to AmerisourceBergen Drug Corp for one unit of Duovisc Viscoelastic System 1.05ML, a pharmaceutical product used in ophthalmic surgical procedures. Awarded on September 9, 2025, with an ultimate completion date of September 10, 2025, this firm fixed price delivery order represents a non-competitive, direct fulfillment from the contractor's existing DLA contract vehicle. The product will be delivered to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp. The $8,960.10 firm fixed price delivery order is for the procurement of 4,567,011 units of the DUOVISC VISCOELASTIC SYSTEM 1.05ML medical product. The contract has an ultimate completion date of January 23, 2025. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, holds a...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXG87Delivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency valued at $5,787.81 for DUOVISC Viscoelastic System 1.05ML. The award was made on September 11, 2025, with an ultimate completion date of September 12, 2025, under a firm fixed price contract structure with no set-aside designation. This delivery order is issued against AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies supporting military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen Drug Corp has demonstrated substantial capacity to fulfill federal medical procurement needs through multiple competitively awarded contracts with the Defense Logistics Agency. The company's contract portfolio encompasses diverse therapeutic categories including specialty medications, brand-name and generic pharmaceuticals, vaccines, and specialized medical devices. The current delivery order for viscoelastic ophthalmic products reflects the company's role in supporting Defense Health Agency operations and broader military healthcare requirements through the DLA Medical Supply Chain network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 9/11/25 |